Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
Department of Health and Human Services · Opportunity RFA-OH-26-015
At a glance AI extracted
Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) (Centers for Disease Control and Prevention - ERA) $0 – $365,000
Who can apply
- Small businesses
- For profit organizations other than small businesses
- Native American tribal organizations (other than Federally recognized tribal gov…
- Nonprofits having a 501(c)(3) status with the IRS
- other than institutions of higher education
Eligible uses
- Health
Typical documents
- Application form (SF-424)
- Project narrative
- Detailed budget
| Award size | $0 – $365,000 |
|---|---|
| Number of awards | 36 |
| Deadline | 2026-06-23 |
| Posted | 2026-05-08 |
| Eligible applicants | Small businesses, For profit organizations other than small businesses, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, City or township governments, Private institutions of higher education, Special district governments, Nonprofits that do not have a 501(c)(3)… |
| Activity | Health |
| Funding instrument | Grant |
| CFDA program | Occupational Safety and Health Program |
| Org type filter | Nonprofit / For-profit / State Gov / Local Gov / Tribal Gov / Individual / K-12AI-tagged |
| Sector filter | Health / Research / Education / CommunityAI-tagged |
| Use filter | Research / TrainingAI-tagged |
| Source | grants.gov |
| Last updated | 2026-05-14T14:08:51.538023+00:00 |
From the official announcement
The World Trade Center (WTC) Health Program supports exploratory and developmental research projects (R21) that address issues related to diagnostic or treatment uncertainty among individuals receiving monitoring and/or treatment under Subtitle C of the James Zadroga 9/11 Health and Compensation Act of 2010, as amended. This R21 Notice of Funding Opportunity (NOFO) is intended to encourage exploratory/developmental research by supporting the early and conceptual stages of project development to assess the feasibility of new areas of investigation with the potential to improve treatment effectiveness and diagnostic practices. These studies may lead to breakthroughs in a particular area or to the development of new interventions, techniques, agents, methodologies, models, or approaches with potential clinical impact. They are expected to break new ground or extend prior discoveries in new directions or applications. Applicants are expected to propose research for which there is likely to be minimal or no preliminary data. Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed. December 8, 2026; October 26, 2027. All applications must be submitted no later than 11:59 pm local time of the applicant organization.
Agency contact
Centers for Disease Control and Prevention - ERA
This page summarizes public information from grants.gov via AI extraction. Final eligibility and application terms are set by the issuing agency. AI summaries may contain errors. Verify on the official announcement before applying.